A Randomized, Open-Label, Single Dose, Crossover Study To Evaluate The Relative Bioavailability Of PF-04457845 Tablet To Solution Formulation And To Assess Food Effect In Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2011
At a glance
- Drugs PF 4457845 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 02 Nov 2011 Results published in the British Journal of Clinical Pharmacology.
- 11 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jun 2009 New trial record